David Bumcrot - 10 Oct 2024 Form 3 Insider Report for Camp4 Therapeutics Corp (CAMP)

Role
Chief Scientific Officer
Signature
By: /s/ Thomas Danielski, Attorney-in-Fact
Issuer symbol
CAMP
Transactions as of
10 Oct 2024
Net transactions value
$0
Form type
3
Filing time
10 Oct 2024, 21:03:54 UTC
Next filing
03 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CAMP Common Stock 61,741 10 Oct 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CAMP Stock Option (Right to Buy) 10 Oct 2024 Common Stock 47 $2.12 Direct F1
holding CAMP Stock Option (Right to Buy) 10 Oct 2024 Common Stock 5,009 $2.12 Direct F1
holding CAMP Stock Option (Right to Buy) 10 Oct 2024 Common Stock 661 $2.12 Direct F1
holding CAMP Stock Option (Right to Buy) 10 Oct 2024 Common Stock 567 $2.12 Direct F1
holding CAMP Stock Option (Right to Buy) 10 Oct 2024 Common Stock 4,348 $2.12 Direct F1
holding CAMP Stock Option (Right to Buy) 10 Oct 2024 Common Stock 4,196 $2.12 Direct F1
holding CAMP Stock Option (Right to Buy) 10 Oct 2024 Common Stock 15,602 $5.50 Direct F2
holding CAMP Stock Option (Right to Buy) 10 Oct 2024 Common Stock 87,607 $8.41 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option is fully vested and exercisable as of the date hereof.
F2 This option had a vesting start date of March 1, 2022 and vests in equal monthly installments over 48 months, beginning on the one-month anniversary of the vesting start date.
F3 This option had a vesting start date of September 1, 2022 and vests in equal monthly installments over 48 months, beginning on the one-month anniversary of the vesting start date.

Remarks:

Exhibit 24 - Power of Attorney